
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.
Click the title above to open the Pharmaceutical Executive November 2016 issue in an interactive PDF format.
almost 10 years ago
Pharm Exec's 2017 Pipeline Reportabout 10 years ago
Digital Disruption is Coming: Are You Ready?about 10 years ago
8 Winning Commercial Portfolio Strategiesabout 10 years ago
Building Market Access Competencies for the Futureabout 10 years ago
Loss of Exclusivity: Strategies to Maximize Product Valueabout 10 years ago
Flipping the Generics Map: Apotex's Jeremy Desaiabout 10 years ago
The Pipeline: Pressures from Beyondabout 10 years ago
Has Gastein Peaked?about 10 years ago
Country Report: Switzerland





